Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.72 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.72 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.72 |
| ▸ | RAB9A | P51151 | 1/20 | 0.72 |
| ▸ | HTT | P42858 | 1/20 | 0.70 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.60 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.58 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.58 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.58 |
| ▸ | BLM | P54132 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29428890 | 1.00 | MEN1 (0.72) | MEN1KMT2ASLC22A6SLC22A8RAB9A | |
| Hydrochloric Acid SCHEMBL8337978 | 0.98 | MEN1 (0.70) | MEN1KMT2ASLC22A6SLC22A8RAB9A | |
| Vanillic Acid SCHEMBL28735586 | 0.93 | HTT (0.83) | MEN1KMT2ASLC22A6SLC22A8RAB9A | |
| Formamide SCHEMBL8336930 | 0.93 | SLC22A6 (0.64) | MEN1KMT2ASLC22A6SLC22A8RAB9A | |
| SCHEMBL29415167 | 0.86 | MAPK1 (0.77) | HTTMAPK1CYP1A2POLBALDH1A1 | |
| SCHEMBL335681 | 0.86 | MAPK1 (0.77) | HTTMAPK1CYP1A2POLBALDH1A1 | |
| SCHEMBL2905586 | 0.85 | RECQL (0.64) | MEN1KMT2ASLC22A6SLC22A8RAB9A | |
| Hydrochloric Acid SCHEMBL5154533 | 0.84 | MAPK1 (0.74) | HTTMAPK1CYP1A2POLBALDH1A1 | |
| SCHEMBL15289000 | 0.84 | MEN1 (1.00) | MEN1KMT2ASLC22A6SLC22A8RAB9A | |
| SCHEMBL15814046 | 0.84 | SLC22A6 (1.00) | MEN1KMT2ASLC22A6SLC22A8RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1310 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250325533-A1 | TRYPTAMINE COMPOSITIONS FOR ENHANCING NEURITE OUTGROWTH | TURTLE BEAR HOLDINGS LLC (US) | 2025-10-23 | — | — | US | claimed |
| EP-2222289-B2 | TREATMENT OF ORAL PHARYNGEAL DYSPHAGIA | NESTLE SA (CH) | 2025-05-14 | — | — | EP | claimed |
| CN-118724760-A | Preparation method of amido guanidine compound and myocardial protection effect thereof | 天津理工大学 | 2024-10-01 | — | — | CN | claimed |
| CN-118549544-A | Separation method of chemical components in capsicum and preparation thereof or construction method of characteristic spectrum | 华润三九现代中药制药有限公司 | 2024-08-27 | — | — | CN | claimed |
| US-11896587-B2 | Tryptamine compositions for enhancing neurite outgrowth | TURTLE BEAR HOLDINGS, LLP (US) | 2024-02-13 | — | — | US | claimed |
| CN-116837016-B | Method for constructing recombinant escherichia coli engineering strain for producing capsaicin-vanilla nonanamide, recombinant strain and application | 中国农业科学院北京畜牧兽医研究所 | 2024-01-02 | — | — | CN | claimed |
| EP-3494104-B1 | WARMING SENSATION COMPOUNDS | TAKASAGO PERFUMERY CO LTD (JP) | 2023-11-15 | — | — | EP | claimed |
| CN-117045609-A | Preparation method of vitamin C tablet | 广州播恩维生素有限公司 | 2023-11-14 | — | — | CN | claimed |
| CN-116837016-A | Method for constructing recombinant escherichia coli engineering strain for producing capsaicin-vanilla nonanamide, recombinant strain and application | 中国农业科学院北京畜牧兽医研究所 | 2023-10-03 | — | — | CN | claimed |
| EP-3335693-B1 | COMPOSITION FOR EXTERNAL USE | OTSUKA PHARMA CO LTD (JP) | 2023-09-13 | — | — | EP | claimed |
| US-5273754-A | A mixture of a heating carminative, vanillylamide, and a cooling carminative, e.g. mint | MANN MORRIS A (US) | 1993-12-28 | — | — | US | claimed |
| WO-1993023061-A1 | THERAPEUTIC USES OF PUNGENT BOTANICALS AND THEIR RELATED COMPOUNDS | STAGGS JEFF J (US) | 1993-11-25 | — | — | WO | claimed |
| EP-0546078-A4 | BIRDFOOD CONTAINING CAPSAICIN OR ITS DERIVATIVES OR ANALOGUES | US HEALTH (US) | 1993-09-15 | — | — | EP | claimed |
| US-5221692-A | Antinociceptives | NATIONAL SCIENCE COUNCIL (TW) | 1993-06-22 | — | — | US | claimed |
| EP-0546078-A1 | BIRDFOOD CONTAINING CAPSAICIN OR ITS DERIVATIVES OR ANALOGUES | THE UNITED STATES OF AMERICA as represented by the Secretary UNITED STATES DEPARTMENT OF COMMERCE (US) | 1993-06-16 | — | — | EP | claimed |
| WO-1992003923-A1 | BIRDFOOD CONTAINING CAPSAICIN OR ITS DERIVATIVES OR ANALOGUES | THE UNITED STATES OF AMERICA, represented by THE SCRETARY, UNITED STATES DEPARTMENT OF COMMERCE (US) | 1992-03-19 | — | — | WO | claimed |
| EP-0242827-B1 | SURFACE SHAPED THERAPEUTIC SYSTEM, METHOD FOR ITS MANUFACTURE, AND ITS APPLICATION | Lohmann GmbH & Co. KG (DE) | 1991-12-27 | — | — | EP | claimed |
| US-4789687-A | FOR REDUCTION OR PREVENTION OF BODY FAT ACCUMULATION | AJINOMOTO CO., INC. (JP) | 1988-12-06 | — | — | US | claimed |
| US-4680313-A | Acceleration of lipid metabolism using vanillylamine derivatives | AJINOMOTO CO., INC. (JP) | 1987-07-14 | — | — | US | claimed |
| EP-0045280-B1 | COMPOSITION FOR THE CONTROL OF SLUGS AND SNAILS, CONTAINER FOR THIS COMPOSITION AND USE OF SUBSTANCES IN PESTICIDES FOR SLUGS AND SNAILS | SIPURO AG (CH) | 1985-04-03 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11896587-B2 | Tryptamine compositions for enhancing neurite outgrowth | HTR1B, HTR6, BDNF | MEN1 1443/4885KMT2A 2403/4885SLC22A6 2984/4885 |
| US-20250325533-A1 | TRYPTAMINE COMPOSITIONS FOR ENHANCING NEURITE OUTGROWTH | HTR1B, BDNF, HTR6 | MEN1 1889/4885KMT2A 1859/4885SLC22A6 3549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.